An Indian vaccine candidate, DengiAll, is in its final testing phase. This single-dose shot offers hope against the deadly dengue disease. ...

India achieves a milestone in dengue prevention. The DengiAll vaccine trial sees 70% participant enrollment. ICMR leads the multi-center st...

India's DengiAll vaccine trial is nearing completion. ICMR scientists anticipate enrolling 10,500 participants by October across 20 Indian ...

Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...

The Indian Council of Medical Research (ICMR) and Panacea Biotec have launched the first phase three clinical trial for an indigenous dengu...

Takeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...

The Dengue Alliance, a coalition of institutions from dengue-endemic countries, plans to develop a new treatment for dengue within five yea...

Until 2012, the dominant strains in India were Dengue 1 and 3, the researchers said. However, in recent years, Dengue 2 has become more dom...

Cases of dengue – a mosquito-borne viral disease – have steadily increased in the last 50 years, predominantly in the South-East Asian coun...

According to the World Health Organization, dengue represents one of the 10 biggest global health threats and it is critical to have access...

This is the Mumbai-based company’s second collaboration focussed on the mosquito-borne virus, the first being its pact to develop a botanic...

Sun Pharma will fund and support further development of the vaccine candidate and existing ICGEB knowhow and patents.

An expert consultative committee of the Indian drug regulatory agency has waived a large-scale clinical trial for a dengue vaccine develope...

If cleared, the step may eventually pave the way for Dengvaxia's availability via the wide government distribution system and private chann...

The injection can thwart all four types of the virus, which has appeared in Portugal, France, Florida and Japan recently, according to WHO.

Serum Institute will develop a drug to treat all 4 strains of dengue, and is in the process of applying for a 'speedy approval' to roll-out...

The study showed that 87% of Indian adults in trial were positive to dengue at enrolment, confirming the significant endemic nature of the ...